Larimar Therapeutics, Inc. (LRMR)

Trade LRMR now with
12/18/2019 6:04:21 AM Zafgen And Chondrial Therapeutics Enter Definitive Merger Agreement
9/5/2019 7:12:19 AM Zafgen Plans To Explore Strategic Options
5/30/2019 7:04:55 AM Zafgen Reports Receipt Of Minutes From Type A Meeting With FDA
1/17/2019 7:03:54 AM Zafgen Announces Positive Data For Second Cohort Of Its Phase 2 Clinical Trial Of ZGN-1061
11/26/2018 7:03:42 AM Zafgen Provides Update On Investigational New Drug Application For ZGN-1061
8/2/2018 4:32:40 PM Navitor Pharmaceuticals Appoints Thomas Hughes As CEO
7/6/2018 5:06:09 AM In The Spotlight: Zafgen
6/28/2018 8:05:03 AM Zafgen Announces Pricing Of Offering Of 8 Mln Shares At $7.50/Shr
6/27/2018 4:04:00 PM Zafgen Announces Proposed Offering Of Common Stock
6/23/2018 10:34:36 AM Zafgen: Phase 2 Proof-of-Concept Trial Of ZGN-1061 Meets All Primary Objectives